Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Terminally modified tri-, tetra- and pentapeptide anaphylatoxin receptor ligands

Terminally modified tri-, tetra- and pentapeptide anaphylatoxin receptor ligands

US Patent 5190922 · Granted Mar 2, 1993

Estimated economic value: $46,325,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

5, 6-D2 uridine nucleoside/tide derivatives2018
Deuterated nucleoside/tide derivatives2017
Chemokine receptor antagonists and methods of use2017
Imidazopyridines as a novel scaffold for multi-targeted kinase inhibition2015
Chemokine receptor antagonists and methods of use thereof2014
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DDP-IV)2014
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)2012
Chemokine receptor antagonists and methods of use therefor2011
Therapeutic compounds and uses thereof2011
Substituted pyrazolo[3,4-d]pyrimidines as protein kinase inhibitors2010
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)2010
Chemokine receptor antagonists and methods of use therefor2009